Chemoinformaics analysis of Sinapaldehyde Glucoside
| Molecular Weight | 370.354 | nRot | 7 |
| Heavy Atom Molecular Weight | 348.178 | nRig | 14 |
| Exact Molecular Weight | 370.126 | nRing | 2 |
| Solubility: LogS | -1.613 | nHRing | 1 |
| Solubility: LogP | -0.401 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 48 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 1 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 6 |
| nHA | 9 | APOL | 50.2774 |
| nHD | 4 | BPOL | 29.8826 |
| QED | 0.355 |
| Synth | 3.776 |
| Natural Product Likeliness | 1.86 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.567 |
| HIA | 0.861 |
| CACO-2 | -5.555 |
| MDCK | 0.000133209 |
| BBB | 0.783 |
| PPB | 0.345356 |
| VDSS | 0.534 |
| FU | 0.397986 |
| CYP1A2-inh | 0.023 |
| CYP1A2-sub | 0.116 |
| CYP2c19-inh | 0.011 |
| CYP2c19-sub | 0.788 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.386 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.445 |
| CYP3a4-inh | 0.005 |
| CYP3a4-sub | 0.037 |
| CL | 2.355 |
| T12 | 0.696 |
| hERG | 0.043 |
| Ames | 0.569 |
| ROA | 0.788 |
| SkinSen | 0.306 |
| Carcinogencity | 0.732 |
| EI | 0.01 |
| Respiratory | 0.943 |
| NR-Aromatase | 0.186 |
| Antiviral | No |
| Prediction | 0.59501 |